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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effects of interventions to increase exercise and all types of physical activity, versus no intervention (exercise and physical
activity as usual) for people with congenital heart disease.
B A C K G R O U N D
Physical activity is increasingly recognized as an important modi-
fying factor for physical fitness and health markers in people (Pate
2013). Physical activity is likewise essential for children and adults
with congenital heart disease (ConHD) (Takken 2011; Tikkanen
2012; Duppen 2013; Longmuir 2013). Despite the growing body
of literature on the benefits of physical activity, a large num-
ber of patients with ConHD do not adhere to recommendations
(Reybrouck 2005; McCrindle 2007).
Physical activity refers to any bodily movements that result in an
increase in energy expenditure above baseline resting energy ex-
penditure (Caspersen 1985). Physical activity can be habitual and
a part of daily living, as well as part of a structured exercise pro-
gram. Physical exercise is defined as a subset of physical activity
that is planned, structured and repetitive, and has as a final or an
intermediate objective the maintenance or improvement of phys-
ical fitness (Caspersen 1985). Physical activity can be assessed by
self-report or objective measures. However, physical activity is dif-
ficult to assess and interpret as no method is accurate. Interven-
tions to increase physical activity are therefore also evaluated by
health outcomes mediated by physical activity such as exercise ca-
pacity, health-related quality of life and risk markers for metabolic
syndrome.
Children and adults with ConHD have reduced exercise capac-
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ity across the different heart defects, in comparison with healthy
people (Kempny 2012). The low level of physical activity in this
population may explain this reduced exercise capacity, along with
restrictions for unknown reasons (Lunt 2003; McCrindle 2007;
Buys 2012a; Buys 2012b; Buys 2013).
The American Heart Association and the European Society of
Cardiology recommend that children and adults with ConHD
should be encouraged to be normally active and to participate
in recreational sport activities (Takken 2011; Longmuir 2013).
However, so far those recommendations are primarily based on
expert opinion (Evidence level 5) rather than scientific evidence
(Klausen 2012). The effects of interventions to increase physical
activity in people with ConHD need to be further investigated
and summarized.
Description of the condition
ConHD can be defined as “a gross structural abnormality of the
heart or intrathoracic great vessels that is actually or potentially
of functional significance” (Mitchell 1971). The reported birth
prevalence worldwide has increased from 0.6 per 1000 live births
in 1934 to 9.1 per 1000 live births after 1995 (van der Linde
2011). This corresponds to 1.35 million live births with ConHD
each year, representing a major public health issue (van der Linde
2011). Before the end of the 1970s, less than 20% of children
born with ConHD survived into adulthood (Warnes 2001). To-
day, 85%are expected to live until adulthood (Moons 2010). Their
children are at increased risk of having a congenital abnormality
(van der Bom 2011).The complexity of the disease varies and is re-
flected in survival rates, comorbidity and health-related quality of
life (Warnes 2001). Genetic syndromes, gestational age and birth
weight, as well as complications after surgery, add to comorbidity
and contribute to the long-term outcomes (Wernovsky 2008).
Description of the intervention
Interventions canbe facility based, homebased or both. Promotion
of and incentives to increase exercise and physical activity can
be undertaken in a multitude of ways and situations. Exercise-
based interventions for people with ConHD may take place at
any relevant time from early childhood to adulthood. The type of
intervention directed at people with ConHD should be adjusted
to age, developmental stage and disease progression.
The first interventions for people with ConHD in the 1980s ex-
amined whether maximal oxygen uptake and exercise capacity
could be safely improved by facility based exercise-based inter-
ventions (Goldberg 1981). As this seemed to be the case, it has
been suggested that exercise-based interventions should become a
part of the routine care of patients with ConHD (Tikkanen 2012;
Duppen 2013).
Interventions to promote physical activity in children and adults
have been encouraged and described (Hirth 2006; Baumgartner
2010; Takken 2011; Longmuir 2013). It is suggested that prac-
titioners should promote physical activity in all medically-stable
children and adults, according to the frequency and intensity rec-
ommended in general population guidelines. Moreover, sedentary
time should be reduced, as prolonged sedentary time has been
associated with negative health outcomes (Thorp 2011). Physical
activity counselling should be based on a clinical assessment at
every patient interaction. Social, cognitive and motivational the-
ories should be used to guide a patient-centred approach, to iden-
tify personal relevant goals and develop an individual action plan
(Longmuir 2013). The evidence for the recommendations is low
(Evidence level 5), mainly based on expert opinion, as the body of
knowledge is limited (Hirth 2006)
From research in other populations with cardiac disease, we know
that exercise-based rehabilitation can lead to increased physical
fitness, increased physical activity levels in daily life and a healthier
lifestyle, which persist after termination of the exercise program
(Vanhees 2012). Also, in individuals with ConHD, rehabilitation
programmes can have persistent beneficial effects, although more
evidence in this population is needed (Longmuir 1990; Rhodes
2005).
How the intervention might work
Physical activity behaviours are affected by personal, social and
environmental factors (Heath 2012). Interventions that address
personal factors to encourage physical activity involving education
on health benefits, motivation and physical training are likely to be
successful (Pate 2013). Education on health benefits and motiva-
tion can be improved by individually-tailored programmes based
on behavioural and social cognitive theories (Kahn 2002).
Interventions mediated by behaviour change techniques, goal set-
ting, feedback and problem-solving aimed at increasing daily phys-
ical activity levels, have proven successful in other fields (Olander
2013). Physical activity can be improved by clarifying the individ-
ual’s specific needs, followed by individual or group-wise guidance
to overcome barriers and fostermotivation (Longmuir 2013).Goal
setting, social support andbehavioural reinforcement through self-
reward and structured problem solving are examples of compo-
nents of these types of interventions. Interventions involving be-
haviour change techniques can be described using a taxonomy in
order to structure and specify the terminology used in invention
studies (Michie 2011).
Self-efficacy is considered to be an important mediator in physical
activity (Bar-Mor 2000; Olander 2013). Self-efficacy is defined as
the belief that one has the ability to engage in a specific behaviour,
such as physical activity (Bandura 1986).
There are convincing data demonstrating that contemporary car-
diac rehabilitation programmes provide direct health benefits,
reduce cardiovascular risk and event rates, increase healthy be-
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haviours and promote active lifestyles (Kwan 2012). Furthermore
there is evidence that a cardiac rehabilitation programme can im-
prove quality of life in different populations with acquired heart
disease (Weberg 2013). It is possible that exercise-based interven-
tions could induce similar benefits in participants with ConHD.
There is a great interest in the association between exercise-based
interventions and health-related quality of life. Health-related
quality of life can be defined as the degree of overall life satisfac-
tion that is positively or negatively influenced by an individual’s
perception of certain aspects of life that are important to them,
including matters both related and unrelated to health (Moons
2004). Davies et al. have shown that exercise training that im-
proves exercise capacity may have a clinically-important effect on
health-related quality of life in people with mild to moderate heart
failure (Davies 2010).The efficacy of physical activity for improv-
ing functional capacity and quality of life is clear in the short-
term, but long-term effects are yet unknown (Piepoli 2013). It is
unknown if exercise-based interventions can impact health-related
quality of life in individuals with ConHD (Kovacs 2005). Studies
have shown that self-assessed physical functioning poorly predicts
actual exercise capacity in adolescents and adults with ConHD
(Gratz 2009). Nevertheless, associations between physical fitness
and different domains of health-related quality of life have been
noted in some studies (Van De Bruaene 2011; Buys 2013). How-
ever, the way these dimensions interact and respond to exercise-
based intervention programs is poorly understood.
Why it is important to do this review
Uncertainty exists as to whether exercise-based interventions are
harmful or beneficial for people with congenital heart disease
(ConHD), and whether current recommendations are effective.
However, undue care/protection may be harmful if it restricts
physical activity. By contrast, strenuous physical exercise may be
harmful to individuals with ConHD due to their heart condi-
tion. There is a growing interest in the association between health-
related quality of life and health-related fitness in people with
ConHD. Trials have examined the effect of exercise training on
physical fitness and health-related quality of life, but no consensus
has been established (Duppen 2013). Thus, a systematic review
of trials testing the interventions for increasing physical activity is
needed to synthesize the evidence on quality of life, health-related
fitness, cardiovascular risk factors and adverse events in people
with ConHD.
This review aims to summarize the results of all randomized tri-
als with an experimental intervention aiming to increase physical
activity in individuals with ConHD. It is important to do this
review, because it includes all interventions that intend to increase
physical activity, and will not solely focus on exercise training. Ha-
bitual physical activities, such as increased leisure time activities
and active transport, will also be included in the review.
O B J E C T I V E S
To assess the effects of interventions to increase exercise and all
types of physical activity, versus no intervention (exercise andphys-
ical activity as usual) for people with congenital heart disease.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomized controlled trials, irrespective of pub-
lication status, blinding status or language.
We will only include unpublished trials if trial data and method-
ological descriptions are provided, either in written form or by
direct contact with the authors.
Types of participants
All children (less than 18 years) and adults with congenital heart
disease, whether or not they underwent surgical or catheter inter-
vention, who are stable and allowed to be physically active.
Types of interventions
All exercise-based interventions, either alone or as a component
of another intervention, with a duration of at least four weeks.
We will include both counselling and education programmes, and
structured exercise training programmes. We will also include in-
terventions involving incentives for increased exercise and physical
activity.
The intervention will be compared to exercise and physical activity
as usual.
An example of counselling or educational programmes might be
the encouragement to be physically active based on the theory
of behavioural change, with encouragement provided either by
group or individual therapy sessions or by innovative methods
using internet or mobile phone applications. Examples of exercise
training programs are: a supervised structured exercise training
program in a cardiac rehabilitation centre, a home-based walking
program supervised with GPS-based tele monitoring, or a non-
supervised home-based exercise program in which patients choose
their own physical activities.
We will include studies in which the exercise-based intervention
is a component of another intervention, such as interventions to
improve motor skills, increase lung function, adopt a healthier
diet, quit smoking, or lose weight.
In both the intervention and control group, participants will re-
ceive usual medical care as defined by the study. Usual medical
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care generally consists of regular follow-up in a tertiary care centre
for congenital heart disease, drug treatment if necessary and the
general advice to live healthily and to be normally active in daily
life, sometimes with exercise restrictions depending on the type of
underlying congenital heart defect (Takken 2011).
Types of outcome measures
Studiesmust report the first primary outcome in both intervention
and control groups in order to be included.
We will extract outcomes at all time points and categorize them
as: up to 6 months follow-up, 6 to 12 months follow-up and more
than 12 months follow-up.
Primary outcomes
1. Health-related quality of life as measured by validated
quality of life measures; determined by questionnaire, generic
and/or disease-specific, reported as a continuous outcome.
2. Serious adverse events (SAE) during maximal follow-up.
We have defined SAEs, according to the International
Conference on Harmonisation Guidelines and the European
Directive (European 2001), as “any untoward medical
occurrence or effect that at any dose results in death, is life-
threatening, requires hospitalisation or prolongation of existing
hospitalisation, results in persistent or significant disability or
incapacity, or is a congenital anomaly or birth defects.”
Secondary outcomes
1. Objective physical activity, determined by accelerometer,
pedometer or heart rate, reported as a continuous outcome.
2. Self-reported physical activity and functioning, determined
by a validated and standardized questionnaire, reported as a
continuous outcome.
3. Exercise capacity: a) peak oxygen consumption Vo2 max or
Vo2 peak; b) Watt max; c) V E/VCO2-minute ventilation/
carbon dioxide production; d) oxygen uptake efficiency slope
(OUES); e) oxygen consumption at ventilatory anaerobic
threshold (AT), determined by cardio-pulmonary exercise test on
treadmill or bicycle ergometer, reported as continuous outcomes.
4. Self-rated health determined by a validated and
standardized questionnaire, reported as a continuous outcome.
5. Gross motor skills, determined by a validated test battery,
reported as a continuous outcome.
6. Muscle function, determined by hand grip strength and
upper leg muscle strength.
Search methods for identification of studies
Electronic searches
We will search the following databases from their inception: The
Cochrane Central Register of Controlled Trials (CENTRAL, The
Cochrane Library), MEDLINE (Ovid), EMBASE (Ovid), BIO-
SIS Citation Index (Thomson Reuters), Web of Science (Thom-
son Reuters), Latin American Caribbean Health Sciences Litera-
ture (LILACS via BIREME), the Chinese Biomedical Literature
Database, advanced Google, and Cumulative Index to Nursing
and Allied Health Literature (CINAHL via EBSCOhost).
We will use a systematic and sensitive search strategy to iden-
tify relevant randomized controlled trials without language or
date restrictions. The preliminary search strategy for MEDLINE
(Appendix 1) will be adapted for use in the other databases.
We will search for ongoing clinical trials and unpublished studies
on the following clinical trial registers:
1. Current Controlled Trials;
2. ClinicalTrials.gov;
3. The WHO International Clinical Trial Registry Platform
(ICTRP) on apps.who.int/trialsearch/.
Searching other resources
We will handsearch the reference list of relevant reviews, random-
ized and non-randomized studies, and editorials for additional
studies. We will contact the main authors of studies and experts
in this field to ask for any missed, unreported or ongoing trials.
Data collection and analysis
Selection of studies
We will provide a detailed description of our search results. Search
results will be merged using reference management software, and
duplicate records will be removed. Paired review authors (LLA and
SHK; RB and SHK), with the lead author being part of all pairs,
will independently assess titles and abstracts retrieved from the
search in order to identify studies for eligibility and remove obvi-
ously irrelevant reports.. Full text of potential relevant reports will
be retrieved. Multiple reports from the same study will be linked
together. Full text reports will be examined for compliance with el-
igibility criteria. Correspondence with investigators will take place
when appropriate to clarify study eligibility.The final selection will
be undertaken by three authors (LLA, RB, SHK). In case of dis-
agreements, decisions will be taken by discussion with an author
who is not a content expert (JW). We will not be blinded to the
author, institution, or the publication source of trials.
Data extraction and management
We will use a data extraction sheet in concordance with inclusion
and exclusion criteria to extract and collect data. The data extrac-
tion sheet will be pilot tested. We will approach all corresponding
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authors of the included trials for additional information relevant
to the review’s outcome measures and ’Risk of bias’ components.
Assessment of risk of bias in included studies
The validity and design characteristics of each trial will be evalu-
ated. We will use the ’Risk of bias’ (ROB) table described in the
Cochrane Handbook, section 8.5 (Higgins 2011) as a tool for as-
sessing risk of bias in included studies. To draw conclusions about
the overall risk of bias for an outcome it is necessary to evalu-
ate the trials for major sources of bias, also defined as domains
(random sequence generation, allocation concealment, blinding,
incomplete outcome data, selective outcome reporting, and other
sources of bias). We will perform separate sensitivity analyses for
patient-reported outcomes (subjective outcomes) and for serious
adverse events (Higgins 2011).
We will define the trials as having low risk of bias only if they ade-
quately fulfil the criteria listed in the Cochrane Handbook (Section
8.5.a) and will perform summary assessments of the risk of bias
for each important outcome (across domains) within and across
studies. We will present a ’Risk of bias graph’ and a ’Risk of bias
summary figure’ (Higgins 2011).
We will assess the risk of bias in the different domains as described
in the Cochrane Handbook (Section 8.5.d; Higgins 2011). The
judgement for each entry involves assessing the risk of bias as ’low
risk’, ’high risk’, or as ’unclear risk’, with the last category indicating
either lack of information or uncertainty over the potential for
bias. In case of significant bias effects in one or more bias domains,
we will highlight the effect-estimate from trials with low or lower
risk bias.
We will present results for all outcomes including adverse events
in a ’Risk of bias summary figure’.
Measures of treatment effect
We will report continuous outcomes and the intervention effects
as standardized mean differences (SMD) with 95% confidence
intervals (CIs) (Higgins 2011).
We will report dichotomous outcomes as relative risks (RR) to-
gether with 95% CIs or, if rare, as Peto odds ratios (POR) with
95% CIs. We will report objective physical activity as a continu-
ous outcome and the intervention effect as mean difference (MD)
with 95% CIs.
Unit of analysis issues
We will include individualised randomized trials as well as cluster
randomized trials. Unit of analysis issues in cluster trials will be
dealth with as described in the Cochrane Handbook (Section 9.3).
We will not include cross-over trials.
Dealing with missing data
We will contact all the first authors and contact persons of the
trials that have missing data in order to request the relevant data.
A modified intention-to-treat (ITT) analysis will be performed
including, if possible, all randomized individuals who were tested
at baseline or who did not withdraw their consent before the in-
tervention.
In cases of missing data, for our primary outcomes we will use a
’complete-case analysis’ by simply excluding all participants with
the outcome missing from the analysis. Additionally, we will con-
duct sensitivity analyses for our primary outcomes by applying
best and worst case scenarios.
Selective outcome reporting occurs when non-significant results
are selectively withheld from publication (Chan 2004). We will
explore selective outcome reporting by comparing publications
with their protocols, if the latter are available.
Assessment of heterogeneity
The degree of heterogeneity observed in the results is quantified
using diversity (D2) (Wetterslev 2009) and inconsistency factor (I
2) statistics, which can be interpreted as the proportion of the total
variation observed between the trials that is attributable to differ-
ences between trials rather than sampling error (chance) (Higgins
2002). P ≤ 0.10 indicates significant heterogeneity, and the sug-
gested I2 statistic thresholds for low, moderate, and high hetero-
geneity are 25% to 49%, 50% to 74%, and ≥ 75% respectively
(Higgins 2003). If I2 = 0, we will report the results using the
fixed-effect model only. In the case of I2 > 0 we will report the
results using both the random-effects and the fixed-effect models.
However, we believe that there is little value in using a fixed-effect
model in cases of substantial heterogeneity, which we suspect will
be present in this review due to the inclusion of various patient
types and outcome reporting. Consequently, we will emphasize
the results from the random-effects model analysis unless a few
trials dominate the meta-analysis (for example more than 50% of
the cumulated fixed weight percentage). Additionally, in cases of
I2 > 0 (for the outcomes) we will seek to determine the cause of
heterogeneity by performingmeta-regression analyses using Com-
prehensive Meta-Analysis (CMA version one) and Stata version
nine, and relevant subgroup and sensitivity analyses. We aim to
combine trial results in a meta-analysis only when clinical hetero-
geneity is low to moderate. We will use the Chi2 test to provide
an indication of heterogeneity between studies, with P ≤ 0.10
considered significant.
Assessment of reporting biases
Publication bias occurs when the publication of research results
depends on their nature and direction (Dickersin 1990). We will
examine this by creating funnel plots in order to detect either
publication bias or a difference between smaller and larger studies
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(small study effects), expressed as asymmetry of the funnel plot
(Egger 1997).
Funding bias is defined as the biases in the design, outcome, and
reporting of industry-sponsored research in order to show that an
intervention has a favourable outcome (Bekelman 2003). Rela-
tionships between industry, scientific investigators and academic
institutions are widespread and often result in conflicts of interest
(Bekelman 2003). We may conduct a sensitivity analysis in order
to examine the role of funding bias, if relevant (see Sensitivity
analysis).
Data synthesis
We will use Review Manager software (RevMan 2012) to synthe-
size data, as well as TSA software version.0.9 (Thorlund 2011).
We will calculate the relative risk (RR) with 95% confidence inter-
vals (CIs) for dichotomous variables (binary outcomes). We will
also calculate the risk difference (Keus 2009). If the results are
similar we will only report the RR. Additionally, we will calculate
mean difference (MD) as the measure of absolute change with
95% CIs for continuous outcomes. If different scales for the same
outcome are used in different trials, we will consider pooling the
results using standardized mean difference (SMD) for continuous
outcomes in order to combine common outcomes with different
measures (e.g. exercise capacity and quality of life).
Adverse effects may be rare but serious, and hence important (
Sutton 2002), whenmeta-analysis is applied for combining results
from several trials that have binary outcomes (that is, event or
no event). Firstly, we will apply the Peto odds ratio (POR) in
the case of small event proportions. Most meta-analytic software
packages do not include options for analyses to calculate RR when
included trials have ’zero events’ in both arms (intervention versus
control). Exempting these trials from the calculation of RR and
CI may lead to overestimation of a treatment effect, as the control
event proportion may be overestimated. Thus we will perform a
sensitivity analysis by applying empirical continuity corrections
to our zero event trials as proposed by Sweeting et al (Sweeting
2004; Keus 2009), by applying an imaginary small mortality in
both arms.
Trial sequential analysis (TSA)
Meta-analyses may result in type 1 errors due to sparse data
and repeated significance testing when meta-analyses are updated
with new trials (Wetterslev 2008; Brok 2009; Wetterslev 2009;
Thorlund 2011). Systematic errors from trials at high risk of bias,
outcome reporting bias, publication bias, early stopping for ben-
efit and small trial bias may result in spurious P values.
In a single trial, interim analysis increases the risk of type 1 er-
rors due to sparse data and repetitive statistical testing. To avoid
type 1 errors, group sequential monitoring boundaries are applied
to decide whether a trial could be terminated early because of a
sufficiently small P value, that is, the cumulative Z curve crosses
the monitoring boundary. Sequential monitoring boundaries can
be applied to meta-analyses as well and are called trial sequential
monitoring boundaries. In ’trial sequential analysis’ (TSA) the ad-
dition of each trial in a cumulative meta-analysis is regarded as
an interim meta-analysis and helps to decide whether additional
trials are needed (Wetterslev 2008).
The idea in TSA is that if the cumulative Z curve crosses the
boundary a sufficient level of evidence is reached and no further
trials may be needed. However, there is insufficient evidence to
reach a conclusion if the Z curve does not cross the boundary or
does not surpass the required information size. To construct the
trial sequential monitoring boundaries (TSMB) the required in-
formation size is needed and will be calculated as the least number
of participants needed in a well-powered single trial (Brok 2008;
Wetterslev 2008). We will adjust the required information size
for heterogeneity with the diversity adjustment factor (Wetterslev
2009). We will apply TSA, since it prevents an increase of the risk
of type 1 error (< 5%) due to potential multiple updating and test-
ing on accumulating data, whenever new trial results are included
in a cumulative meta-analysis. This provides us with important
information in order to estimate the level of evidence on the exper-
imental intervention (Pogue 1997; Pogue 1998; Thorlund 2009).
Additionally, TSA provides important information regarding the
need for additional trials and their required sample size (Wetterslev
2008;Wetterslev 2009).We will apply trial sequential monitoring
boundaries according to a required information size estimated by
a 10% difference in health-related quality of life at end of follow
up. We will apply trial sequential monitoring boundaries accord-
ing to an information size suggested by the trials at low risk of bias
(Wetterslev 2008; Wetterslev 2009) and an a priori 20% relative
risk reduction (RRR) of serious adverse events (SAEs) using a con-
trol event proportion suggested by large observational studies and
by the pooled estimate of the event proportion in the included
trial control groups. As SAEs seem rare in the trials conducted so
far, and hence the ability to detect small intervention effects is low,
we will also perform a TSA with an information size estimated
based on an a priori 35% RRR of SAEs (Wetterslev 2009).We will
also apply trial sequential monitoring boundaries according to a
required information size estimated by a 10% difference in work
capacity analysed byVO2(ml/min), VCO2(ml/min),VE (Pl/min),
Watt max (watt) at end of follow up. We will use an anticipated
Diversity of 25% to adjust the required information size and we
will also use the Diversity actually measured from the included
trials in the meta-analyses.
Subgroup analysis and investigation of heterogeneity
If possible we will conduct subgroup analysis based on type of
exercise intervention, frequency (times per week), intensity, time
(minutes per session), and type (strength training or cardiovas-
cular training). We will report the authors’ classifications of the
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intensity of the exercise intervention as mild, moderate or vigor-
ous. Furthermore, if possible, we will conduct subgroup analyses
based on the different underlying heart defects (or groups of heart
defects according to severity).
We will only make inferences from the subgroup analysis in terms
of implications for clinical practice if the overall analysis of one of
the co-primary outcomes becomes statistically significant. Where
the analyses of the co-primary outcomes do not become statisti-
cally significant, we intend to reference them in ’Implications for
research’ to provide possible hypothesis generation for further re-
search.
We will compare intervention effects in subgroups using a test
of interaction (Altman 2003). We consider P < 0.05 to indicate
significant interaction between the effect of increased physical ac-
tivity on SAEs and health-related quality of life and the subgroup
category ’frequency, intensity, time and type’ (Higgins 2011).
We will explore the causes of moderate to high heterogeneity using
meta-regression that includes the following covariates, if possible:
mean age of the trial population at baseline; mean body mass
index (BMI) of trial population at baseline; and proportion of
individuals in each New York Heart Association (NYHA) class in
the trial population at baseline.
Clinical relevance tables will be compiled for pooled outcome
measures in additional tables to improve the readability of the
review.
We will discuss minimal clinically important difference (MCID),
defined as “the smallest change inQOLwhich individuals perceive
as beneficial” (Thorlund 2011)..
Sensitivity analysis
As there is no sufficiently well-designed formal statistical method
to combine the results of trials which are at high and low risk of
bias, we will incorporate our ’Risk of bias’ assessment by restricting
meta-analyses to studies at low (or lower) risk of bias (Higgins
2011). Further sensitivity analysis, should there be sufficient trials,
will take into account:
• a continuous correction of trials with zero events
• size of trial (e.g. comparing small and large trials)
• data from trials only published in abstracts compared to
those in published papers
• industry versus public funding of trials
Wewill calculate RRwith 95%CI applying complete case analysis,
if possible, for the sensitivity and subgroup analyses based on SAEs
and health-related quality of life outcomes.
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15. bicycle$.tw.
16. ((lifestyle or life-style) adj5 activ$).tw.
17. ((lifestyle or life-style) adj5 physical$).tw.
18. (physical$ adj5 (fit$ or train$ or activ$ or endur$ or exert$ or perform* or inact*)).tw.
19. anaerobic.tw.
20. rehabilitat$.tw.
21. heart rate recovery.tw.
22. danc*.tw.
23. (run* or jog*).tw.
24. or/1-23
25. exp Heart Defects, Congenital/
26. exp Heart Diseases/cn [Congenital]
27. (heart adj2 (defect* or abnormal* or malform*)).tw.
28. (congenital adj2 (heart or cardiac or cardio*)).tw.
29. or/25-28
30. 24 and 29
31. randomised controlled trial.pt.







39. 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38
40. exp animals/ not humans.sh.
41. 39 not 40
42. 30 and 41
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